Toxicology & Substance Abuse

Benzodiazepines/Ketamine/Gamma-Hydroxybutyric Acid Combo Rapid Test (BZO/KET/GHB)

Powered by NomoFlow™

Results in 5 minutes Detects BZO, KET, and GHB Easy to use urine sample No instrumentation required

Rapid urine test for the simultaneous detection of Benzodiazepines (BZO), Ketamine (KET), and Gamma-Hydroxybutyric Acid (GHB). Results in minutes, easy to use.

A Foundation of Trust

Powered by NomoFlow™
CE
Marked
ISO 13485

Why Choose Our BZO/KET/GHB Combo Rapid Test?

Our Benzodiazepines/Ketamine/Gamma-Hydroxybutyric Acid Combo Rapid Test provides a fast, convenient, and reliable method for detecting multiple substances of abuse. Using a simple urine sample, the test delivers accurate results in just 5 minutes, making it ideal for on-site testing and immediate decision-making. Its multi-analyte detection saves time and resources.

Inside NomoFlow™: The Source of This Test's Superior Performance

The BZO/KET/GHB Combo Rapid Test demonstrates excellent clinical performance characteristics for each analyte.

Clinical Performance Characteristics

Analyte Sensitivity (PPA) Specificity (NPA) Overall Agreement
Benzodiazepines (BZO) 92.0% (95% CI: 83.5% - 96.9%) 98.0% (95% CI: 94.2% - 99.5%) 96.5%
Ketamine (KET) 90.0% (95% CI: 80.9% - 95.7%) 97.0% (95% CI: 92.7% - 99.0%) 95.0%
Gamma-Hydroxybutyric Acid (GHB) 91.0% (95% CI: 82.2% - 96.2%) 96.5% (95% CI: 92.0% - 98.6%) 94.0%

Relevant studies and publications will be available here soon.

Time to Result 5 minutes
Sample Type Urine
Cut-off (BZO) 300 ng/mL
Cut-off (KET) 1000 ng/mL
Cut-off (GHB) 10 ng/mL
Kit Size 25 Tests/Kit
Storage Conditions 2-30u00b0C
Shelf Life 24 Months
Included Materials Test devices, package insert
Required Materials (Not Included) Timer, urine collection container
Certifications CE, ISO 13485

1

Collect Urine Sample

Collect urine sample in a clean container.

2

Apply Sample to Device

Add the required amount of urine to the sample well of the test device.

3

Read Results

Read the test results at 5 minutes. Do not interpret after 10 minutes.

Product Information

  • Catalog Number: DOA-BKG30
  • Product Name: Benzodiazepines/Ketamine/Gamma-Hydroxybutyric Acid Combo Rapid Test (BZO/KET/GHB)

Download product-related documents here:

Support

Frequently Asked Questions

Direct answers regarding clinical performance, workflow, and logistics.

The cutoff levels are 300 ng/mL for Benzodiazepines (BZO), 1000 ng/mL for Ketamine (KET), and 10 ng/mL for Gamma-Hydroxybutyric Acid (GHB).
This test demonstrates high accuracy for each analyte with sensitivity and specificity greater than 90%.

Have more specific technical or clinical questions?

Connect with a Clinical Application Specialist

For Clinical Professionals

Integrate into a Complete Respiratory Workflow

This test is a key component of a broader strategy for managing respiratory outbreaks, optimizing resource allocation, and improving patient outcomes. See how it fits into a complete workflow solution.

Explore Workflow Solutions

For Strategic Partners

Inject the Power of NomoFlow™ into Your Brand

Build your brand on our foundation of verifiable reliability. Our platform is available for OEM/ODM partnerships, offering superior products with complete manufacturing transparency.

Discover Partnership Value

Take the Next Step Towards Verifiable Reliability

Equip your facility with diagnostic tools engineered for certainty. Select your path below to get started.

Experience the Difference

Request evaluation samples for your laboratory validation.

Request Samples

Clinical Consultation

Discuss workflow integration with an application specialist.

Contact Support

Commercial Partnership

Inquire about distribution or OEM/ODM opportunities.

Become a Partner